SPIRE1 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.962000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.233400E-01
Normal-vs-Stage2
5.265400E-01
Normal-vs-Stage3
9.577400E-01
Normal-vs-Stage4
6.013000E-01
Stage1-vs-Stage2
6.790600E-01
Stage1-vs-Stage3
3.267000E-01
Stage1-vs-Stage4
6.985800E-01
Stage2-vs-Stage3
4.368000E-01
Stage2-vs-Stage4
8.994600E-01
Stage3-vs-Stage4
4.990000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.820800E-01
Normal-vs-AfricanAmerican
7.181000E-01
Normal-vs-Asian
9.447400E-01
Caucasian-vs-AfricanAmerican
6.391600E-01
Caucasian-vs-Asian
2.859700E-02
AfricanAmerican-vs-Asian
4.899800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
4.659600E-01
Normal-vs-Female
5.448800E-01
Male-vs-Female
3.214200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.809400E-01
Normal-vs-Age(41-60Yrs)
2.934800E-01
Normal-vs-Age(61-80Yrs)
6.534800E-01
Normal-vs-Age(81-100Yrs)
8.398800E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.940800E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.830400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
8.476400E-02
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.963280E-03
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.700900E-03
Age(61-80Yrs)-vs-Age(81-100Yrs)
5.716400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
8.034800E-01
Normal-vs-Daily Drinker
6.877600E-01
Normal-vs-Weekly Drinker
7.544400E-01
Normal-vs-Occasional Drinker
2.606600E-01
Normal-vs-Social Drinker
2.739000E-01
Non Drinker-vs-Daily Drinker
4.305800E-01
Non Drinker-vs-Weekly Drinker
8.435400E-01
Non Drinker-vs-Occasional Drinker
6.593900E-02
Non Drinker-vs-Social Drinker
4.318400E-02
Daily Drinker-vs-Weekly Drinker
5.311200E-01
Daily Drinker-vs-Occasional Drinker
8.492800E-01
Daily Drinker-vs-Social Drinker
3.635000E-01
Weekly Drinker-vs-Occasional Drinker
1.909240E-01
Weekly Drinker-vs-Social Drinker
7.408500E-02
Occasional Drinker-vs-Social Drinker
2.930200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.313600E-01
Normal-vs-Grade 2
2.377800E-01
Normal-vs-Grade 3
1.907800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.446590E-01
Grade 1-vs-Grade 3
7.960000E-01
Grade 1-vs-Grade 4
4.313600E-01
Grade 2-vs-Grade 3
1.261960E-02
Grade 2-vs-Grade 4
2.377800E-01
Grade 3-vs-Grade 4
1.907800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
6.751600E-01
Normal-vs-NonDiabetic
4.974800E-01
Diabetic-vs-NonDiabetic
2.606800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
5.835200E-01
Normal-vs-NoPancreatitis
4.992600E-01
Pancreatitis-vs-NoPancreatitis
9.389400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.608800E-01
Normal-vs-N1
5.525000E-01
N0-vs-N1
4.084200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.777400E-01
Normal-vs-TP53-NonMutant
4.869800E-01
TP53-Mutant-vs-TP53-NonMutant
7.952400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
